| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |